001060
vs
MRK
001060
MRK
Over the past 12 months, JW Pharmaceutical Corp has significantly outperformed MRK, delivering a return of +54% compared to the MRK's +33% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
001060
MRK
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
JW Pharmaceutical Corp
KRX:001060
|
32 050
KRW
|
|||||
|
Merck & Co Inc
NYSE:MRK
|
119.63
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
001060, MRK
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
JW Pharmaceutical Corp
Revenue
|
|||||||||||
|
|
Merck & Co Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
001060, MRK
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
JW Pharmaceutical Corp
KRX:001060
|
|||||||||
|
|
Merck & Co Inc
NYSE:MRK
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
JW Pharmaceutical Corp | ||||
|
|
Merck & Co Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
001060, MRK
Performance By Year
001060, MRK
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
